Impact BioMedical Inc.
AMEXIBO short interest rebounded 7.4% in one day to 0.90% of free float, reversing a 23% weekly decline. Cost to borrow fell sharply to 51.6% from peaks above 100% in mid-April as pressure eased.
Snapshot as of 30 Jun 2026
No long-form analysis yet for IBO. Pulse alerts and the live data picture are available on ORTEX.
Open IBO on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IBO — free to start on ORTEX.
Sign up for free →Open IBO on ORTEX